
Opinion|Videos|March 14, 2025
How Bispecific Antibodies Are Reshaping Cancer Care
Experts discuss how the availability of bispecific therapies has influenced treatment paradigms in oncology and how bispecifics fit into current treatment algorithms for hematologic malignancies and solid tumors.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How has the availability of bispecific therapies influenced treatment paradigms in oncology?
- How do bispecifics fit into current treatment algorithms for hematologic malignancies and solid tumors?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care
2
Semaglutide Shows Promise for Steatohepatitis Resolution in MASH
3
Socioeconomic Factors Linked to Surgical Outcomes in Upper Extremity Soft Tissue Sarcoma
4
FDA Draft Guidance Proposes CR, MRD to Accelerate MM Drug Approval
5






























































